So let me get this straight.
Clinical trial results are due this month (after months of delays).
CEO has been appointed - 3 March 2022 & the unlisted options have an exercise price of 8/12/16c respectively.
Merchant Funds Management on the register.
Exclusive worldwide license - Dolce Cann Global (<0.3%) THC
Always had conviction here, nothing has changed. Bought more today.
Ann: Medicinal Cannabis Presentation, page-7
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.001(1.92%) |
Mkt cap ! $52.76M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.1¢ | 5.0¢ | $47.84K | 954.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 291484 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 399999 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| NTI (ASX) Chart |